Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- HAS -4.6%, STT -2.1%
Select metals/mining stocks trading lower:
- HMY -3%, AUY -1.1%, KGC -0.5%, GG -0.5%, GLD -0.5%, ABX -0.5%, .
Other news:
- CNXR -46.9% (to voluntarily delist from Nasdaq, will list on the OTCQX Market effective on or about November 9)
- DBVT -45.7% (announces topline results of phase III clinical trial in peanut allergic patients four to 11 years of age; missed primary endpoint)
- SHIP -19.4% (files for $20 mln common stock offering)
- ATRS -13.8% (receives Complete Response Letter for XYOSTED from the FDA)
- GBT -9.7% (to discontinue its GBT440 program for the treatment of idiopathic pulmonary fibrosis based on results from three proof-of-concept studies)
- MYO -9.2% (files for $6 mln common stock and warrants offering)
- GEO -1.3% (files mixed securities shelf offering)
- ZSAN -0.6% (entered into a common stock purchase agreement with Lincoln Park Capital for up to $35 million)
Analyst comments:
- CLF -2.7% (downgraded to Neutral from Overweight at JP Morgan)
- MELI -2.4% (downgraded to Sector Weight from Overweight at KeyBanc Capital Mkts )
- FL -1.4% (downgraded to Neutral from Buy at Buckingham Research)
- GE -1.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley; downgraded to Neutral from Buy at UBS)
- RIO -1.1% (downgraded to Sector Perform at RBC Capital Mkts)
- EFX -0.9% (downgraded to Sector Perform at RBC Capital Mkts)
- RRC -0.8% (downgraded to Neutral from Overweight at JP Morgan)
- BIIB -0.7% (downgraded to Neutral from Buy at Citigroup)